Logo image of PFE.DE

PFIZER INC (PFE.DE) Stock Fundamental Analysis

Europe - FRA:PFE - US7170811035 - Common Stock

20.93 EUR
+0.61 (+3.03%)
Last: 9/30/2025, 5:28:05 PM
Fundamental Rating

5

Taking everything into account, PFE scores 5 out of 10 in our fundamental rating. PFE was compared to 51 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PFE while its profitability can be described as average. PFE scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PFE had positive earnings in the past year.
PFE had a positive operating cash flow in the past year.
PFE had positive earnings in each of the past 5 years.
PFE had a positive operating cash flow in each of the past 5 years.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

PFE has a Return On Assets (5.22%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 12.12%, PFE is in line with its industry, outperforming 54.90% of the companies in the same industry.
PFE's Return On Invested Capital of 7.61% is in line compared to the rest of the industry. PFE outperforms 47.06% of its industry peers.
PFE had an Average Return On Invested Capital over the past 3 years of 10.06%. This is significantly below the industry average of 15.11%.
Industry RankSector Rank
ROA 5.22%
ROE 12.12%
ROIC 7.61%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of PFE (16.84%) is better than 68.63% of its industry peers.
In the last couple of years the Profit Margin of PFE has declined.
With a decent Operating Margin value of 28.52%, PFE is doing good in the industry, outperforming 78.43% of the companies in the same industry.
PFE's Operating Margin has improved in the last couple of years.
PFE has a better Gross Margin (73.96%) than 72.55% of its industry peers.
In the last couple of years the Gross Margin of PFE has declined.
Industry RankSector Rank
OM 28.52%
PM (TTM) 16.84%
GM 73.96%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

PFE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, PFE has more shares outstanding
The number of shares outstanding for PFE has been increased compared to 5 years ago.
Compared to 1 year ago, PFE has an improved debt to assets ratio.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

An Altman-Z score of 2.13 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
PFE has a Altman-Z score (2.13) which is in line with its industry peers.
PFE has a debt to FCF ratio of 4.97. This is a neutral value as PFE would need 4.97 years to pay back of all of its debts.
PFE has a Debt to FCF ratio (4.97) which is in line with its industry peers.
PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating PFE is somewhat dependend on debt financing.
PFE has a Debt to Equity ratio (0.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.97
Altman-Z 2.13
ROIC/WACC0.85
WACC8.95%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 1.16 indicates that PFE should not have too much problems paying its short term obligations.
The Current ratio of PFE (1.16) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.85 indicates that PFE may have some problems paying its short term obligations.
PFE has a Quick ratio (0.85) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.85
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 151.11% over the past year.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
Looking at the last year, PFE shows a quite strong growth in Revenue. The Revenue has grown by 13.54% in the last year.
PFE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.10% yearly.
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%

3.2 Future

Based on estimates for the next years, PFE will show a decrease in Earnings Per Share. The EPS will decrease by -4.48% on average per year.
The Revenue is expected to decrease by -2.85% on average over the next years.
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.48%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.24 indicates a rather cheap valuation of PFE.
Based on the Price/Earnings ratio, PFE is valued cheaply inside the industry as 90.20% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.67. PFE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 7.65, the valuation of PFE can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 88.24% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. PFE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.24
Fwd PE 7.65
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PFE is valued cheaper than 86.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PFE is valued cheaper than 84.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.22
EV/EBITDA 6.89
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFE does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)10.99
PEG (5Y)6.82
EPS Next 2Y1.57%
EPS Next 3Y0.49%

6

5. Dividend

5.1 Amount

PFE has a Yearly Dividend Yield of 7.14%, which is a nice return.
Compared to an average industry Dividend Yield of 3.03, PFE pays a better dividend. On top of this PFE pays more dividend than 100.00% of the companies listed in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

PFE pays out 89.68% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP89.68%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

PFIZER INC

FRA:PFE (9/30/2025, 5:28:05 PM)

20.93

+0.61 (+3.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners67.15%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap119.00B
Analysts70.67
Price Target24.98 (19.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend1.44
Dividend Growth(5Y)3.3%
DP89.68%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.18%
Min EPS beat(2)32.91%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)43.14%
Min EPS beat(4)32.52%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)56.64%
EPS beat(12)12
Avg EPS beat(12)44.11%
EPS beat(16)16
Avg EPS beat(16)37.53%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)6.96%
Revenue beat(4)3
Avg Revenue beat(4)5.79%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.23%
Revenue beat(12)8
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)3.45%
PT rev (1m)-2.48%
PT rev (3m)-1.8%
EPS NQ rev (1m)2.76%
EPS NQ rev (3m)-15.73%
EPS NY rev (1m)0.4%
EPS NY rev (3m)3.1%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)0.2%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 7.24
Fwd PE 7.65
P/S 2.19
P/FCF 11.22
P/OCF 9.19
P/B 1.57
P/tB N/A
EV/EBITDA 6.89
EPS(TTM)2.89
EY13.81%
EPS(NY)2.74
Fwd EY13.08%
FCF(TTM)1.87
FCFY8.91%
OCF(TTM)2.28
OCFY10.89%
SpS9.58
BVpS13.31
TBVpS-4.95
PEG (NY)10.99
PEG (5Y)6.82
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 12.12%
ROCE 10.81%
ROIC 7.61%
ROICexc 8.26%
ROICexgc 38.29%
OM 28.52%
PM (TTM) 16.84%
GM 73.96%
FCFM 19.48%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
ROICexc(3y)11.54%
ROICexc(5y)11.73%
ROICexgc(3y)46.07%
ROICexgc(5y)42.74%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score7
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.97
Debt/EBITDA 2.3
Cap/Depr 40.51%
Cap/Sales 4.31%
Interest Coverage 5.77
Cash Conversion 60.76%
Profit Quality 115.66%
Current Ratio 1.16
Quick Ratio 0.85
Altman-Z 2.13
F-Score7
WACC8.95%
ROIC/WACC0.85
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%
EBIT growth 1Y65.39%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year16.68%
EBIT Next 3Y5.82%
EBIT Next 5Y3.57%
FCF growth 1Y16.62%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y4.31%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%